
|Videos|February 3, 2016
The Challenge of High Cost Drugs in Specialty Pharmacy
Author(s)Davy James, Managing Editor
Michael Zeglinski, vice president of Specialty Pharmacy Operations at BriovaRx, discusses how expensive hepatitis C drugs have impacted the specialty landscape.
Advertisement
Michael Zeglinski, vice president of Specialty Pharmacy Operations at BriovaRx, discusses how expensive hepatitis C drugs have impacted the specialty landscape.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Scrutiny of GLP-1 Compounding Is Just Getting Started, Expert Says
2
Menin Inhibitors in AML: Frequently Asked Questions
3
Do GLP-1 Receptor Agonists Increase the Risk of Smell and Taste Disturbances?
4
From Misnomer to Meaning: A Patient-Centered Shift from PCOS to PMOS
5


















































































































